7
38. Following hysterectomy for benign disease, routine screening for
vaginal cancer is NOT recommended for persons with HIV. Those
with a history of high-grade CIN adenocarcinoma in situ or invasive
cervical cancer should be followed with annual vaginal cuff Pap tests.
Anal Cancer Screening
39. Persons with a history of receptive anal intercourse, abnormal
cervical Pap test results, and all persons with genital warts should
have an anal Pap test if access to appropriate referral for follow-up,
including high-resolution anoscopy, is available.
Glucose-6-Phosphate Dehydrogenase
40. Screening for glucose-6-phosphate dehydrogenase (G6PD)
deficiency is recommended before starting therapy with oxidant
drugs such as dapsone, primaquine, or sulfonamides in patients with
a predisposing racial or ethnic background.
Pregnancy Testing
41. All persons of childbearing potential should have a pregnancy test
upon initiation of care or reengagement in care.
Serum Testosterone Level
42. Morning serum testosterone levels are recommended in adult
cisgender men with decreased libido, erectile dysfunction, reduced
bone mass or low trauma fractures, hot flashes, or sweats.
43. Obtaining testosterone levels in women at baseline in non-research
settings is NOT recommended.
Tests NOT Recommended for General Screening Purposes
44. Routine testing for HSV IgG, CMV IgG, Toxoplasma IgG, and
biomarkers of inflammation is
NOT recommended.
45. Testing for serum cryptococcal antigen may be considered in
persons with CD4 <100 cells/mm
3
or in symptomatic patients.
